{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT02162420",
            "orgStudyIdInfo": {
                "id": "2013OC127"
            },
            "secondaryIdInfos": [
                {
                    "id": "MT2013-34C",
                    "type": "OTHER",
                    "domain": "University of Minnesota Blood and Marrow Transplant Program"
                }
            ],
            "organization": {
                "fullName": "Masonic Cancer Center, University of Minnesota",
                "class": "OTHER"
            },
            "briefTitle": "Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia",
            "officialTitle": "Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia",
            "therapeuticArea": [
                "Other"
            ],
            "study": "hematopoietic-stem-cell-transplant-for-dyskeratosis-congenita-or-severe-aplastic-anemia"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2015-01-10",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2014-06-10",
            "studyFirstSubmitQcDate": "2014-06-10",
            "studyFirstPostDateStruct": {
                "date": "2014-06-12",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2024-01-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Masonic Cancer Center, University of Minnesota",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true
        },
        "descriptionModule": {
            "briefSummary": "Fludarabine-based preparative regimen followed by an allogeneic hematopoietic stem cell transplant using related or unrelated donor in persons 0-70 years of age diagnosed with dyskeratosis congenita or severe aplastic anemia who have bone marrow failure characterized by a requirement for red blood cell and platelet transfusions. Three different preparative regimens are included based on disease and donor type."
        },
        "conditionsModule": {
            "conditions": [
                "Dyskeratosis Congenita",
                "Aplastic Anemia"
            ],
            "keywords": [
                "severe aplastic anemia",
                "Hematopoietic Stem Cell Transplant"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Treatment Plan for Dyskeratosis Congenita",
                    "type": "EXPERIMENTAL",
                    "description": "Fludarabine based preparative regimen, including alemtuzumab, cyclophosphamide, fludarabine, and total body irradiation, followed by stem cell transplant for the treatment of dyskeratosis congenita.",
                    "interventionNames": [
                        "Drug: Alemtuzumab",
                        "Drug: Fludarabine",
                        "Drug: Cyclophosphamide",
                        "Biological: Stem Cell Transplant"
                    ]
                },
                {
                    "label": "Treatment for Severe Aplastic Anemia",
                    "type": "EXPERIMENTAL",
                    "description": "Fludarabine based preparative regimen which includes: cyclophosphamide, fludarabine, rabbit ATG and total body irradiation. Followed by stem cell transplant.",
                    "interventionNames": [
                        "Drug: Fludarabine",
                        "Drug: Cyclophosphamide",
                        "Radiation: Total Body Irradiation",
                        "Biological: Stem Cell Transplant",
                        "Drug: Anti-thymocyte globulin"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Alemtuzumab",
                    "description": "Alemtuzumab 0.2 mg/kg IV over 2 hours on days -10 to -6 from transplant.",
                    "armGroupLabels": [
                        "Treatment Plan for Dyskeratosis Congenita"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fludarabine",
                    "description": "Fludarabine 40 mg/m2 IV over 1 hour on days -6 to -2 from transplant.",
                    "armGroupLabels": [
                        "Treatment Plan for Dyskeratosis Congenita",
                        "Treatment for Severe Aplastic Anemia"
                    ],
                    "otherNames": [
                        "Fludara"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Cyclophosphamide",
                    "description": "Cyclophosphamide 50 mg/kg IV over 2 hours on day -7 from transplant.",
                    "armGroupLabels": [
                        "Treatment Plan for Dyskeratosis Congenita",
                        "Treatment for Severe Aplastic Anemia"
                    ]
                },
                {
                    "type": "RADIATION",
                    "name": "Total Body Irradiation",
                    "description": "TBI 200 cGy as a single fraction on day -1 from transplant.",
                    "armGroupLabels": [
                        "Treatment for Severe Aplastic Anemia"
                    ],
                    "otherNames": [
                        "TBI"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Stem Cell Transplant",
                    "description": "Stem cell transplant on day 0.",
                    "armGroupLabels": [
                        "Treatment Plan for Dyskeratosis Congenita",
                        "Treatment for Severe Aplastic Anemia"
                    ],
                    "otherNames": [
                        "HSCT"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Anti-thymocyte globulin",
                    "description": "ATG (Thymoglobulin - Rabbit ) 3 mg/kg IV on days -5 to -3 from stem cell transplant.",
                    "armGroupLabels": [
                        "Treatment for Severe Aplastic Anemia"
                    ],
                    "otherNames": [
                        "Rabbit ATG"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of neutrophil engraftment",
                    "description": "Incidence of neutrophil engraftment by day 42.",
                    "timeFrame": "Day 42"
                },
                {
                    "measure": "Incidence of platelet engraftment",
                    "description": "Incidence of platelet engraftment at 1 year",
                    "timeFrame": "1 year"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Incidence of regimen related mortality",
                    "description": "Incidence of regimen related mortality by day 100.",
                    "timeFrame": "Day 100"
                },
                {
                    "measure": "Incidence of acute graft-versus-host disease",
                    "description": "Incidence of acute graft-versus-host disease by day 100.",
                    "timeFrame": "Day 100"
                },
                {
                    "measure": "Incidence of chronic graft-versus-host disease",
                    "description": "Incidence of chronic graft-versus-host disease by 6 months",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Incidence of chronic graft-versus-host disease",
                    "description": "Incidence of chronic graft-versus-host disease by 1 year",
                    "timeFrame": "1 Year"
                },
                {
                    "measure": "Incidence of secondary malignancies",
                    "description": "Incidence of secondary malingancies",
                    "timeFrame": "1 Year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Aged 0 - 70 years\n* Acceptable hematopoeitic stem cell donor\n* Dyskeratosis Congenita (DC) with evidence of BM failure defined as:\n\n  * requirement for red blood cell and/or platelet transfusions or\n  * requirement for G-CSF or GM-CSF or erythropoietin or\n  * refractory cytopenias having one of the following three\n\n    * platelets \\<50,000/uL or transfusion dependent\n    * absolute neutrophil count \\<500/uL without hematopoietic growth factor support\n    * hemoglobin \\<9g/uL or transfusion dependent\n* Diagnosis of DC with a triad of mucocutaneous features:\n\n  * oral leukoplakia\n  * nail dystrophy\n  * abnormal reticular skin hyperpigmentation, or\n* Diagnosis of DC with one of the following:\n\n  * short telomeres (under a research study)\n  * mutation in telomerase holoenzyme (DKC1, TERT, TERC, NOP10, NHP2, TCAB1)\n  * mutation in shelterin complex (TINF2)\n  * mutation in telomere-capping complex (CTC1)\n* Severe Aplastic Anemia (SAA) primary transplant with evidence of BM failure:\n\n  * Refractory cytopenia defined by bone marrow cellularity \\<50% (with \\< 30% residual hematopoietic cells)\n* Diagnosis of SAA with refractory cytopenias having one of the following three:\n\n  * platelets \\<20,000/uL or transfusion dependent\n  * absolute neutrophil count \\<500/uL without hematopoietic growth factor support\n  * absolute reticulocyte count \\<20,000/uL\n* Severe Aplastic Anemia (SAA) requiring a 2nd transplant\n\n  * Graft failure as defined by blood/marrow chimerism of \\< 5%\n* Early myelodysplastic features\n* With or without clonal cytogenetic abnormalities\n* Adequate organ function defined as:\n\n  * cardiac: left ventricular ejection fraction \u2265 35% with no evidence of decompensated heart failure\n  * pulmonary: DLCO \u226530% predicted, no supplemental oxygen requirement\n  * renal: Glomerular filtration rate (GFR) \u226530% predicted\n* Voluntary written consent\n\nExclusion Criteria:\n\n* Acute hepatitis or evidence of moderate or severe portal fibrosis or cirrhosis on biopsy\n* Pregnant or lactating\n* Uncontrolled infection\n* Prior radiation therapy (applies to SAA patients only)\n* Diagnosis of Fanconi anemia based on DEB\n* Diagnosis of dyskeratosis congenita with advanced MDS or acute myeloid leukemia with \\>30% blasts",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "0 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Timothy Krepski",
                    "role": "CONTACT",
                    "phone": "612-273-2800",
                    "email": "tkrepsk1@fairview.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jakub Tolar, MD",
                    "affiliation": "University of Minnesota",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Minnesota Medical Center, Fairview",
                    "status": "RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55455",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Timothy Krepski",
                            "role": "CONTACT",
                            "phone": "612-273-2800",
                            "email": "tkrepsk1@fairview.org"
                        },
                        {
                            "name": "Jakub Tolar, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000740",
                    "term": "Anemia"
                },
                {
                    "id": "D000000741",
                    "term": "Anemia, Aplastic"
                },
                {
                    "id": "D000019871",
                    "term": "Dyskeratosis Congenita"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000080983",
                    "term": "Bone Marrow Failure Disorders"
                },
                {
                    "id": "D000001855",
                    "term": "Bone Marrow Diseases"
                },
                {
                    "id": "D000080984",
                    "term": "Congenital Bone Marrow Failure Syndromes"
                },
                {
                    "id": "D000012868",
                    "term": "Skin Abnormalities"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                },
                {
                    "id": "D000040181",
                    "term": "Genetic Diseases, X-Linked"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000012873",
                    "term": "Skin Diseases, Genetic"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4070",
                    "name": "Anemia",
                    "asFound": "Anemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4071",
                    "name": "Anemia, Aplastic",
                    "asFound": "Aplastic Anemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21754",
                    "name": "Dyskeratosis Congenita",
                    "asFound": "Dyskeratosis Congenita",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2241",
                    "name": "Bone Marrow Failure Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M13118",
                    "name": "Pancytopenia",
                    "relevance": "LOW"
                },
                {
                    "id": "M5134",
                    "name": "Bone Marrow Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M2242",
                    "name": "Congenital Bone Marrow Failure Syndromes",
                    "relevance": "LOW"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M15672",
                    "name": "Skin Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M24877",
                    "name": "Genetic Diseases, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15676",
                    "name": "Skin Diseases, Genetic",
                    "relevance": "LOW"
                },
                {
                    "id": "T460",
                    "name": "Aplastic Anemia",
                    "asFound": "Aplastic Anemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1976",
                    "name": "Dyskeratosis Congenita",
                    "asFound": "Dyskeratosis Congenita",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003520",
                    "term": "Cyclophosphamide"
                },
                {
                    "id": "C000024352",
                    "term": "Fludarabine"
                },
                {
                    "id": "D000074323",
                    "term": "Alemtuzumab"
                },
                {
                    "id": "D000000961",
                    "term": "Antilymphocyte Serum"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000018906",
                    "term": "Antineoplastic Agents, Alkylating"
                },
                {
                    "id": "D000000477",
                    "term": "Alkylating Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000019653",
                    "term": "Myeloablative Agonists"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6727",
                    "name": "Cyclophosphamide",
                    "asFound": "Effect of",
                    "relevance": "HIGH"
                },
                {
                    "id": "M283230",
                    "name": "Fludarabine",
                    "asFound": "Rate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M225513",
                    "name": "Fludarabine phosphate",
                    "relevance": "LOW"
                },
                {
                    "id": "M255823",
                    "name": "Thymoglobulin",
                    "relevance": "LOW"
                },
                {
                    "id": "M4279",
                    "name": "Antilymphocyte Serum",
                    "asFound": "Chronic Obstructive Pulmonary Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1347",
                    "name": "Alemtuzumab",
                    "asFound": "Transcranial Direct Current Stimulation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20942",
                    "name": "Antineoplastic Agents, Alkylating",
                    "relevance": "LOW"
                },
                {
                    "id": "M3820",
                    "name": "Alkylating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}